Recent Finacing
Recent Raise
Ember Therapeutics develops large- and small-molecule programs that activate adult brown fat and create peripherally acting, CDK5-phosphorylation-targeted insulin sensitizers to treat Type 2 diabetes and obesity.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor